Banner for leaf pages 2

Nilotinib (Tasigna)

Also known as Tasigna

Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a tyrosine kinase inhibitor approved for the treatment of chronic myelogenous leukemia.

Source: Wikipedia

Estimated Total Cost: $6625.66 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed nilotinib to treat leukemia, rabies, pick disease, and blastomycosis.

Ajax-loader Loading...